Introduction {#Sec1}
============

The characteristic cell envelope of *Corynebacterineae* contain mycolic acids, arabinogalactan (AG) and peptidoglycan, which are covalently linked together to form the mycolyl--arabinogalactan--peptidoglycan (mAGP) complex (reviewed in Dover et al. [@CR12]). In addition to the mAGP complex, other glycolipids, such as phosphatidyl-*myo*-inositol (PI) mannosides (PIMs) and lipoglycans, termed lipomannan (LM) and lipoarabinomannan (LAM) are characteristic of this taxon (Besra et al. [@CR4]). LM and LAM possess important physiological and immune functions attributed to a variety of terminal-capping motifs (Nigou et al. [@CR36]), including ManLAM (Chatterjee et al. [@CR8]; Khoo et al. [@CR24]) and PILAM (Gilleron et al. [@CR19]). *M. tuberculosis* and *M. leprae* produce ManLAM, which enables them to infect macrophages and dendritic cells (Schlesinger et al. [@CR41]; Tascon et al. [@CR43]). ManLAM inhibits the production of proinflammatory cytokines, such as IL-12 and TNF-α and inhibits phagosomal maturation (Knutson et al. [@CR26]; Nigou et al. [@CR36]; Fratti et al. [@CR15]), while PILAM from a *Mycobacterium smegmatis* strain induces the proliferation of these cytokines (Adams et al. [@CR1]; Gilleron et al. [@CR19]).

The current model of *Corynebacterineae* lipoglycan biosynthesis follows two divergent pathways. Firstly, PI → PIM → LM-A → LAM (Besra et al. [@CR4]), and secondly, GroAc~2~ → GlcAGroAc~2~ → ManGlcAGroAc~2~ → LM-B (Tatituri et al. [@CR44]) (Fig. [1](#Fig1){ref-type="fig"}). In the first pathway, mycobacterial PI is glycosylated by a α-mannopyranosyl (Man*p*) residue, a reaction catalyzed by PimA (Rv2610c), which transfers Man*p* from GDP-mannose to the 2-position of PI to form PIM~1~ (Kordulakova et al. [@CR27]). PIM~1~ is further acylated (Rv2611c; Kordulakova et al. [@CR28]) and mannosylated by a reaction catalyzed by PimB (Rv0557) resulting in the formation of Ac~1~PIM~2~ (Schaeffer et al. [@CR39]). More recently, however PimB (now also termed MgtA) in *C. glutamicum* has been shown to be exclusively involved in synthesizing a novel mannosylated glycolipid, 1,2-di-*O*-C~16~/C~18:1~-(α-[d]{.smallcaps}-mannopyranosyl)-(1 → 4)-(α-[d]{.smallcaps}-glucopyranosyluronic acid)-(1 → 3)-glycerol (ManGlcAGroAc~2~) (Tatituri et al. [@CR44]). Previous studies have shown that RvD2-ORF1 from *M. tuberculosis* CDC1551, designated as PimC, catalyzed further α-mannosylation of Ac~1~PIM~2~, resulting in Ac~1~PIM~3~ (Kremer et al. [@CR29]). Recently, PimE (Rv1159) has been shown to be involved in higher PIM biosynthesis and directly in the biosynthesis of Ac~1~PIM~5~ (Morita et al. [@CR34]).Fig. 1Schematic representation of MGDAG and PIM pathway for lipoglycan synthesis in *Corynebacterianae*

The core mannan backbone is glycosylated by Rv2181 and results in the synthesis of α(1 → 2)-Man*p* linked branches, characteristic of the mannan backbone in LM and LAM (Kaur et al. [@CR22]). Recently, Mishra et al. ([@CR33]) and Kaur et al. ([@CR23]) reported a novel α-mannosyltransferase, MptA (Rv2174), involved in the latter stages of LM/LAM biosynthesis in *Corynebacterineae*. The mature LM is then elaborated with arabinose by EmbC to form LAM (Berg et al. [@CR3]). Recently a novel mannosyltransferase, MT1671 (and Rv1635c), has been shown to add terminal Man*p* residues to the mature LAM in *M. tuberculosis* to form ManLAM (Dinadayala et al. [@CR10]; Appelmelk et al. [@CR2]).

In this study, we have examined an NCgl2106 null mutant of *C. glutamicum* and established that NCgl2106 is a phosphatidyl-*myo*-inositol monomannoside mannopyranosyltransferase exclusively involved in the synthesis of Ac~1~PIM~2~ from Ac~1~PIM~1~, now termed Cg-*pimB′* (Lea-Smith et al. [@CR30]) (Fig. [1](#Fig1){ref-type="fig"}). In addition, the utilisation of this mutant strain allowed the isolation and chemical analysis of a novel lipoglycan, now termed Cg-LM-B, based on a GlcAGroAc~2~ anchor rather than a PI-based anchor, which typifies *Corynebacterineae* LM and LAM. Moreover, purification of Cg-LM-A and Cg-LM-B, has allowed an evaluation of their pro-inflammatory properties.

Materials and methods {#Sec2}
=====================

Strains and culture conditions {#Sec3}
------------------------------

The wild type of *Corynebacterium glutamicum*, ATCC 13032, was grown on either the complex medium Brain Heart Infusion (BHI) (Difco) or a salt medium CGXII (Eggeling and Bott [@CR13]) at 30°C. The *Escherichia coli* strain DH5 was grown on LB at 37°C. Kanamycin and ampicillin were used at a concentration of 25 or 50 μg/ml, wherever appropriate. Samples for lipid analysis were prepared by harvesting the cells at an optical density 600 nm of 10--15 followed by a saline wash and freeze drying.

Construction of plasmids and strains {#Sec4}
------------------------------------

To construct the deletion vector pK19mobsacBΔ2106 crossover PCR was applied with primer pairs Nout2106/Nin2106 (Nout2106, AATCGGAGATCCGAGACCGGG; Nin2106, CCCATCCACTAAACTTAAACATTTTCGGGATGCAGACACAAAGA) (all primers in 5′--3′ direction) and Cout2106/Cin2106 (Cout2106, ACCCAGTTGTCAGCGCCTTGAG; Cin2106, TGTTTAAGTTTAGTGGATGGGCGGTTGACCAATATTTTGCAGAG) with *C. glutamicum* genomic DNA as template. Both amplified products were used in a second PCR with primer pairs Nout2106/Cout2106 to generate a 1025 bp fragment consisting of sequences adjacent to NCgl2106, which was made blunt, phosphorylated and ligated with *Sma*I-cleaved pK19mobsacB. The chromosomal deletion of NCgl2106 was performed as described previously using two rounds of positive selection (Schafer et al. [@CR40]), and its successful deletion verified by use of two different primer pairs. Plasmids were introduced into *C. glutamicum* by electroporation with selection to kanamycin resistance (25 μg/ml) on BHI. To enable expression of NCgl2106 in the deletion mutant, NCgl2106 was amplified using the primer pair CGCGGATCCAAGGAG ATATAGATATGTCTGCATCCCGAAAAACTCTC and CGCGAATTCTCATCGTGGTTCACTCTGC. The purified PCR fragment was digested with *Bam*HI-*Eco*RI and ligated with pEKEx2 (Eikmanns et al. [@CR14]). All cloned fragments were verified by sequencing.

Lipid extraction and purification of lipoglycans {#Sec5}
------------------------------------------------

Polar lipids and apolar lipids were extracted as described previously (Dobson et al. [@CR11]). The polar lipid extract was examined by 2D-TLC on aluminum backed plates of silica gel 60 F~254~ (Merck 5554), using CHCl~3~/CH~3~OH/H~2~O (60:30:6, v/v/v) in the first direction and CHCl~3~/CH~3~COOH/CH~3~OH/H~2~O (40:25:3:6, v/v/v/v) in the second direction. *C. glutamicum* glycolipids were visualized by spraying plates with either α-naphthol/sulfuric acid, Dittmer & Lester Reagent, or 5% ethanolic molybdophosphoric acid followed by gentle charring of plates. Glycolipids were further purified into individual species by preparative TLC on 10 cm × 20 cm plastic backed TLC plates of silica gel 60 F~254~ (Merck 5554), run in chloroform/methanol/water (60:30:6, v/v/v). The plates were then sprayed with 0.01% 1,6-diphenyl-1,3,5-hexatriene dissolved in petroleum ether/acetone (9:1 v/v) and the glycolipids visualized under UV light. Following detection the plates were re-developed in toluene to remove diphenyl-1,3,5-hexatriene and the corresponding glycolipid bands were scraped from the plates and extracted from the silica gel using chloroform/methanol (2:1, v/v). Samples were prepared for MALDI-TOF-MS as described previously (Tatituri et al. [@CR44]). Lipoglycans from *C. glutamicum* strains were extracted and purified as described previously (Nigou et al. [@CR35]; Ludwiczak et al. [@CR31]; Tatituri et al. [@CR44]).

Permethylation of Cg-LM-B prior to MALDI-TOF analysis {#Sec6}
-----------------------------------------------------

Permethylation was performed using the sodium hydroxide procedure as described previously (Dell et al. [@CR9]). MALDI-TOF and TOF/TOF MS data on permethylated samples were acquired in the positive ion mode (M + Na)^+^ using a 4800 (Applied Biosystems) mass spectrometer in the reflector mode with delayed extraction. The collision energy was set to 1 kV, and argon was used as collision gas for MS/MS data collection. Samples were dissolved in methanol, and 1 μl was mixed at a 1:1 ratio (v/v) with 2,5-dihydrobenzoic acid (20 mg/ml in 70% methanol in water) as matrix.

Gas chromatography--mass spectrometry linkage analysis {#Sec7}
------------------------------------------------------

Partially methylated alditol acetates were prepared from permethylated samples for gas chromatography--mass spectrometry (GC--MS) linkage analysis as described (Dell et al. [@CR9]). The partially methylated alditol acetates were analyzed using a PerkinElmer Clarus 500 instrument fitted with a RTX-5 column (30 m × 0.25-mm internal diameter, Restek Corp.). The sample was dissolved in hexane and injected onto the column at 65°C. The column was maintained at this temperature for 1 min and then heated to 290°C at a rate of 8°C per min.

TNF-α production by human macrophage cell line {#Sec8}
----------------------------------------------

THP-1 human monocyte/macrophage cell line was maintained in continuous culture with RPMI 1640 medium (Lonza), 10% fetal calf serum (Lonza) in an atmosphere of 5% CO~2~ at 37°C, as non-adherent cells. Lipoglycans at concentrations of 5 or 15 μg/ml were added in triplicate to cells (10^5^ cells/well) in 96-well culture plates and then incubated for 16 h at 37°C. Supernatants were assayed for TNF-α by sandwich ELISA using commercially available kits and according to manufacturer's instructions (R&D Systems).

Results {#Sec9}
=======

Construction and growth of *C. glutamicum*Δ*pimB′* {#Sec10}
--------------------------------------------------

We found that the gene product of NCgl0452 of *C. glutamicum*, respectively its ortholog Rv0557 in *M. tuberculosis*, originally termed PimB and now termed MgtA (Tatituri et al. [@CR44]), primarily acts as an α-mannosyltransferase to add mannose to GlcAGroAc~2~ (Tatituri et al. [@CR44]). This study also highlighted the presence of a lipomannan, now termed Cg-LM-B, based on a GlcAGroAc~2~ anchor rather than a PI-anchor. Further characterization of Cg-LM-B was hampered due to co-migration and co-elution following size exclusion chromatography with the PI-based Cg-LM-A (Tatituri et al. [@CR44]). To investigate the structure and function of Cg-LM-B further we adopted a strategy based on the existence of two pathways to lipoglycan synthesis (Fig. [1](#Fig1){ref-type="fig"}) and to identify Cg-*pimB′* involved in Ac~1~PIM~2~ synthesis whereby disruption would block *C. glutamicum* LM/LAM synthesis while Cg-LM-B would be unaffected. We searched for unknown glycosyltransferases using nucleotide-activated sugars. Amongst others we identified NCgl2106 in the genome of *C. glutamicum* with orthologs present in all *Corynebacterianeae* including *Mycobacterium* species.

In order to delete NCgl2106 in the wild type of *C. glutamicum*, we constructed the non-replicative plasmid pK19mobsacB∆2106. This was used to transform *C. glutamicum* to kanamycin resistance, indicating integration in its chromosome (Fig. [2](#Fig2){ref-type="fig"}a). Loss of vector was obtained by selection for sucrose-resistance yielding clones with NCgl2106 deleted. A PCR analysis with primers hybridizing outside of the sequences used for strain construction resulted in the expected fragment of 2159 bp for the wild type and of 1088 bp for the deletion mutant, which was termed *C. glutamicum*Δ*pimB′*.Fig. 2Construction of inframe deletion mutant of *pimB′* in *C. glutamicum* and resulting phenotype. (**a**) Strategy to delete *pimB′* by use of vector pK19mobsacBΔ*pimB′* by two homologous recombination events with the wild type chromosome *C. glutamicum* (*Cg*-WT). The deletion is demonstrated on the right via PCR using primer pairs P5/P6 showing the expected 1088 bp fragment for the deletion mutant in the lane marked "Δ", and that of 2159 bp for the wild type marked "W". The lane marked "St" is the standard consisting of BstEII-fragments of λ-DNA, with arrowheads positioned at 0.70, 1.37, 2.32, and 3.68 kb. (**b**) TLC-analysis of PIM biosynthesis in *C. glutamicum*, *C. glutamicum*Δ*pimB′* and *C. glutamicum*Δ*pimB′* pEKEx2*-pimB′*. Glycolipids were visualized by spraying plates with α-naphthol/sulfuric acid, followed by gentle charring of TLC plates. (**c**) Lipoglycan profiles of *C. glutamicum* strains analyzed using SDS-PAGE and visualized using a Pro-Q emerald glycoprotein stain (Invitrogen) specific for carbohydrates. The major bands represented by Cg-LAM, Cg-LM-A, and Cg-LM-B are indicated. The four major standard bands indicated on the side of the gel represent glycoproteins of 180, 82, 42 and18 kDa, respectively

Polar lipid analysis {#Sec11}
--------------------

Lyophilised cells were extracted using petroleum-ether and methanolic saline to recover apolar lipids. Further processing of the methanolic extract afforded the polar lipid fraction, which was examined by two-dimensional thin-layer chromatography (2D-TLC). The extract from wild type *C. glutamicum* showed the presence of ManGlcAGroAc~2~, GlcAGroAc~2~ (Gl-A) and Ac~1~PIM~2~, by α-naphthol/sulfuric acid staining (Fig. [2](#Fig2){ref-type="fig"}b). Surprisingly, while the synthesis of ManGlcAGroAc~2~ and GlcAGroAc~2~ remained unaffected the component corresponding to Ac~1~PIM~2~ identified by negative ion mode MALDI-MS at *m/z* 1398 \[M-H\]^−^ with the fatty acyl groups C~16~ and C~18:1~ (Tatituri et al. [@CR44]) was absent in *C. glutamicum*Δ*pimB′* with the appearance of a new product, which was sugar (Fig. [2](#Fig2){ref-type="fig"}b) and phosphate positive (data not shown) by specific staining. This predominant lipid spot was purified and corresponded to Ac~1~PIM~1~, which was confirmed by negative ion mode MALDI-MS analyses due to the characteristic ion at *m*/*z* 1236 (M-H)^−^ (data not shown). Complementation of *C. glutamicum*Δ*pimB′* by pEKEx2-Cg-*pimB′* restored the wild type phenotype (Fig. [2](#Fig2){ref-type="fig"}b). Altogether, the data indicated that Ac~1~PIM~1~ in *C. glutamicum*Δ*pimB′* occurs possibly as a result of inactivation of a phosphatidyl-*myo*-inositol mannosyltransferase, presumably which transfers a mannopyranosyl (Man*p*) residue from GDP-Mannose to the 6-position of Ac~1~PIM~1~. In addition this data also shed further light on the acylation step in PIM biosynthesis in *Corynebacterianeae*. The accumulation of Ac~1~PIM~1~ in *C. glutamicum*Δ*pimB′* showed that the acylation step (Kordulakova et al. [@CR28]) precedes the second mannosylation step in PIM biosynthesis, and results in the formation of Ac~1~PIM~2~ (Schaeffer et al. [@CR39]).

Lipoglycans were extracted by refluxing delipidated cells in ethanol, followed by hot-phenol extraction, protease digestion and dialysis to remove impurities. The extracted lipoglycans were examined initially on 15% SDS-PAGE (Fig. [2](#Fig2){ref-type="fig"}c). Extracts from wild type *C. glutamicum* showed the presence of Cg-LAM, Cg-LM-A and Cg-LM-B (Tatituri et al. [@CR44]). As expected the lipoglycan extract from *C. glutamicum*Δ*pimB′* showed the absence of Cg-LAM and Cg-LM-A, and the presence of a single species (Cg-LM-B) by chemical characterization as described below. Complementation of *C. glutamicum*Δ*pimB′* by transformation with plasmid pEKEx2-Cg-*pimB′* restored the wild type phenotype of Cg-LAM, Cg-LM-A and Cg-LM-B (Fig. [2](#Fig2){ref-type="fig"}c). As predicated, the inactivation of Cg-PimB′ abolished the synthesis of Cg-LAM and Cg-LM-A, and provided a strain that allowed the purification of Cg-LM-B for further chemical and functional characterisation. Cg-LM-B from *C. glutamicum*Δ*pimB′* and Cg-LM-A from *C. glutamicum*Δ*pimB′* (Tatituri et al. [@CR44]) were purified by hydrophobic interaction chromatography (HIC) and size exclusion chromatography.

Analysis of Cg-LM-B by mass spectrometry {#Sec12}
----------------------------------------

The Cg-LM-B was permethylated prior to detailed mass spectrometric analysis. During the permethylation step the acyl groups from the lipoglycan are liberated and the glycerol hydroxyl groups are methylated. The MALDI-TOF MS profile of the permethylated sample in the positive mode showed no signals for ManGlcAGro (*m/z* 579) but, interestingly, a series of peaks (M + Na^+^) corresponding to the addition of 4--22 hexose residues to the GlcAGro core structure. In the lower mass region of the spectrum, signals consistent with the elongation of the GlcAGro core were observed at *m/z* 1191.7, 1395.8 and 1600.0 corresponding to the compositions Hex~4~GlcAGro, Hex~5~GlcAGro and Hex~6~GlcAGro, respectively (data not shown). Peaks corresponding to Hex~7~GlcAGro and Hex~9~GlcAGro were absent from the spectrum. At higher mass, signals were observed corresponding to a series of Hex~n~GlcAGro units containing even numbers of hexoses at *m/z* 2008.2, 2416.4, 2824.6, 3232.8, 3641.0, 4049.2, 4457.2 and 4865.6 with Hex~12~GlcAGro (*m/z* 2824.6) being most abundant (Fig. [3](#Fig3){ref-type="fig"}a). The low abundance of signals attributable to components carrying an odd number (Hex11, 13, 15, 17, 19 and 21) of hexoses (*m/z* 2620.5, 3028.7, 3436.9, 3849.0, 4252.2 and 4660.4), as compared to even numbered, suggests that the hexose polymer is branched rather than linear. In addition, there are also signals present in the MS spectrum attributable to hexose oligomers. This may result from partial degradation of the sample during preparation but could also be due to contamination. Each of the major signals in the spectrum was subjected to collision induced decomposition MS/MS (CID-MS/MS) analysis to establish their structures. For example, MS/MS spectra of the signal at *m/z* 2416, which has the composition Hex~10~GlcAGro, showed peaks at *m/z* 2198, 1994, 1585.6, 1381.5, 1177.5, 769.3 and 361 (Fig. [3](#Fig3){ref-type="fig"}b) which are due to the loss of 1, 2, 4, 5, 6, 8 and 10 hexose units from the molecular ion. The inset to Fig. [3](#Fig3){ref-type="fig"}b shows the likely sequence that is consistent with this set of fragment ions.Fig. 3MALDI-TOF/TOF analysis of permethylated Cg-LM-B \[M + Na^+^\] Man~n~GlcAGro. (**a**) MS spectrum of the dervatized Cg-LM-B. Unassigned peaks (\*) are due to permethylation artifacts. (**b**) CID-MS/MS analysis of *m/z* 2416 (M + Na^+^) Man~10~GlcAGroAc. A possible structure and CID fragmentation pattern of peak *m/z* 2416 is depicted in the cartoon representation, inset. Circle-mannose; diamond-glucuronic acid

In order to confirm the nature of the hexose units and linkages, GC/MS analysis of partially methylated alditol acetates was carried out. This revealed the presence of terminal mannose, 2 linked mannose, 2,6 linked mannose (data not shown). The presence of t-Man and 2,6-Man convincingly establishes that the backbone of the oligomannans is heavily branched. The relative abundances of t-Man (1.0), 6-Man (0.5) and 2,6-Man (0.98) are consistent with single mannose residues being appended at O-2 to the 6-linked mannosyl backbone.

TNF-α production by human macrophage cell line in response to Cg-LMs {#Sec13}
--------------------------------------------------------------------

PI-anchored lipoglycans, and most particularly LMs, isolated from other actinomycete genera, including mycobacteria, have previously been shown to induce cytokine production by phagocytic cells (Garton et al. [@CR16]; Gibson et al. [@CR17]; Quesniaux et al. [@CR38]). We thus investigated the potency of both types of Cg-LMs to stimulate the release of TNF-α using a human macrophage cell line. As expected, the PI-anchored LM, Cg-LM-A, elicited a dose-dependent production of the cytokine (Fig. [4](#Fig4){ref-type="fig"}). However interestingly, the GlcAGroAc~2~-anchored LM, Cg-LM-B, was also found to be as stimulatory as the PI-anchored LM, suggesting that the phospho-*myo*-inositol unit of the anchor in LM does not play a key role in lipoglycan pro-inflammatory activity.Fig. 4TNF-α production by human macrophage cell line in response to Cg-LMs. Cg-LM-A was isolated and purified as described previously (Tatituri et al. [@CR44]) and Cg-LM-B (this study) were tested at 5 (grey bars) and 15 (black bars) μg/ml

Discussion {#Sec14}
==========

SDS-PAGE analysis of purified lipoglycans from *C. glutamicum*Δ*pimB′* showed the presence of a single species, which migrated akin to Cg-LM. Chemical characterization of this novel species using MS-MS established it as an oligomer of hypermannosylated oligosaccharides linked to GlcAGroAc~2~. It was previously established that these glycosylated diacylglycerols function as precursors/anchors for hyperglycosylated variants, such as the lipomannans, as found in the case of dimannosyl diacylglycerols in *Micrococcus* and lipoteichoic acids (Pakkiri and Waechter [@CR37]). Moreover, related di- and monoacylglycerols containing glucuronosyl residues have been well reported in *Pseudomonas* sp. (Wilkinson [@CR46]) *Bacillus cereus* T (Minnikin et al. [@CR32]), and halotolerant bacteria (Stern and Tietz [@CR42]). The data in relation to *Mycobacterium* are sparse in regards to the presence of glycosyl diacylglycerols, except for a few limited cases, such as a diglucosyl diacylglycerol (Hunter et al. [@CR21]). In *Mycobacterium smegmatis*, a minor glucuronosyl diacylglycerol glycolipid has been reported (Wolucka et al. [@CR47]), and uronosyl-containing glycopeptidolipids in *Mycobacterium avium* (Chatterjee et al. [@CR7]) and *Mycobacterium habana* (Khoo et al.[@CR25]). Our results also support our initial hypothesis that ManGlcAGroAc~2~ also participates in the biosynthesis of a novel Cg-LM-like molecule and that the Cg-LM most likely consists of two components, a minor Cg-LM based on ManGlcAGroAc~2~ (Cg-LM-B) and a more abundant component akin to the characteristic dominant mycobacterial PI-based LM (Cg-LM-A) (Tatituri et al. [@CR44]). The presence of a Cg-LM-B type species may exist in *Mycobacterium*, based on the identification as mentioned earlier of a minor glucuronosyl diacylglycerol glycolipid (Wolucka et al. [@CR47]), and further experiments are needed to address this question. It is also interesting to also note that Cg-LM-A is arabinosylated, yet Cg-LM-B, which possesses a similar mannan is not arabinosylated. A possibility for this structural difference maybe that Cg-LM-B is more heavily branched than Cg-LM-A thereby removing potential sites for arabinosylation leading to Cg-LAM.

LM-like molecules are powerful pro-inflammatory lipoglycans found in the cell-walls of mycobacteria and some related actinomycetes genera (Garton et al. [@CR16]; Gibson et al. [@CR17]; Quesniaux et al. [@CR38]), including *Corynebacterium* (Tatituri et al. [@CR44]). They are composed of two parts, a PI anchor to which is attached an α-[d]{.smallcaps}-mannan domain, that both play a key role in their ability to induce cytokine production by phagocytic cells. The PI-acylation pattern is also critical for activity (Gilleron et al. [@CR20]) and the latter is abrogated after deacylation of LM by alkaline treatment (Gibson et al. [@CR18]). But the structure of the glycosidic moiety has also been shown to modulate the pro-inflammatory activity of the molecule. Indeed, the presence of an arabinan domain such as in the case of LAM-like molecules undermines lipoglycan activity by masking the mannan domain (Vignal et al. [@CR45]; Gibson et al. [@CR17]). In addition, LM activity seems also to be modulated by the presence or not of side chains on the mannan domain as well as the size of these chains (Gibson et al. [@CR18]). We have shown that *C. glutamicum* contains two types of LM that share a similar mannan domain but differ by their lipidic anchor, one bearing a classical PI anchor and the other one based on a GlcAGroAc~2~ anchor (Tatituri et al. [@CR44]). In the present study, aided by two different mutants, which are selectively affected in the biosynthesis pathway of each type of LM, we have managed to separate them. We found that both LMs induced a similar amount of cytokine secretion by a human macrophage cell line, indicating that the PI part of Cg-LM-A does not play a key role in lipoglycan pro-inflammatory activity. Since the completion of these studies and preparation of manuscript, Lea-Smith et al. ([@CR30]) have reported similar findings on the role of Cg-PimB′. However, their study did not analyze the structural basis of Cg-LM-B in detail and report on the pro-inflammatory properties of this lipoglycan in comparison to Cg-LM-A, which is now reported in this present study. Finally, a proposed hypothetical pathway that takes into account the potential role of MgtA and PimB′, the accumulation of Ac~1~PIM~1~ and Cg-LM-B, and abrogation of ManGlcAGroAc~2~ (Tatituri et al. [@CR44]) and Ac~1~PIM~2~ is presented in Fig. [1](#Fig1){ref-type="fig"}.
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